This topic contains a solution. Click here to go to the answer

Author Question: A genetic variation in how the metabolite of the cancer drug irinotecan SN-38 is inactivated by the ... (Read 31 times)

strangeaffliction

  • Hero Member
  • *****
  • Posts: 660
A genetic variation in how the metabolite of the cancer drug irinotecan SN-38 is inactivated by the body may lead to:
 
  1. Decreased effectiveness of irinotecan in the treatment of cancer
  2. Increased adverse drug reactions, such as neutropenia
  3. Delayed metabolism of the prodrug irinotecan into the active metabolite SN-38
  4. Increased concerns for irinotecan being carcinogenic

Question 2

Patients who have a poor metabolism phenotype will have:
 
  1. Slowed metabolism of a prodrug into an active drug, leading to accumulation of prodrug
  2. Accumulation of inactive metabolites of drugs
  3. A need for increased dosages of medications
  4. Increased elimination of an active drug



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

jordangronback

  • Sr. Member
  • ****
  • Posts: 339
Answer to Question 1

2

Answer to Question 2

1





 

Did you know?

The longest a person has survived after a heart transplant is 24 years.

Did you know?

Famous people who died from poisoning or drug overdose include, Adolf Hitler, Socrates, Juan Ponce de Leon, Marilyn Monroe, Judy Garland, and John Belushi.

Did you know?

Pope Sylvester II tried to introduce Arabic numbers into Europe between the years 999 and 1003, but their use did not catch on for a few more centuries, and Roman numerals continued to be the primary number system.

Did you know?

If all the neurons in the human body were lined up, they would stretch more than 600 miles.

Did you know?

Bacteria have been found alive in a lake buried one half mile under ice in Antarctica.

For a complete list of videos, visit our video library